TY - JOUR
T1 - Ethnic Disparity in Mortality Among Ischemic Heart Disease Patients. A-20 Years Outcome Study From Israel
AU - Abu-Much, Arsalan
AU - Nof, Eyal
AU - Bragazzi, Nicola Luigi
AU - Younis, Anan
AU - Hochstein, David
AU - Younis, Arwa
AU - Shlomo, Nir
AU - Fardman, Alexander
AU - Goldenberg, Ilan
AU - Klempfner, Robert
AU - Beinart, Roy
N1 - Publisher Copyright:
Copyright © 2021 Abu-Much, Nof, Bragazzi, Younis, Hochstein, Younis, Shlomo, Fardman, Goldenberg, Klempfner and Beinart.
PY - 2021
Y1 - 2021
N2 - Background: Long-term morbidity and mortality data among ischemic heart disease (IHD) patients of different ethnicities are conflicting. We sought to determine the independent association of ethnicity and all-cause mortality over two decades of follow-up of Israeli patients. Methods: Our study comprised 15,524 patients including 958 (6%) Arab patients who had been previously enrolled in the Bezafibrate Infarction Prevention (BIP) registry between February 1, 1990, and October 31, 1992, and subsequently followed-up for long-term mortality. We compared clinical characteristics and outcomes of Israeli Arabs and Jews. Propensity score matching (PSM) (1:2 ratios) was used for validation. Results: Arab patients were significantly younger (56 ± 7 years vs. 60 ± 7 years; p < 0.001; respectively), and had more cardiovascular disease (CVD) risk factors. Kaplan-Meier survival analysis showed that all-cause mortality was significantly higher among Arab patients (67 vs. 61%; log-rank p < 0.001). Multivariate adjusted analysis showed that mortality risk was 49% greater (HR 1.49; 95% CI: 1.37–1.62; p < 0.001) among Arabs. Conclusions: Arab ethnicity is independently associated with an increased 20-year all-cause mortality among patients with established IHD.
AB - Background: Long-term morbidity and mortality data among ischemic heart disease (IHD) patients of different ethnicities are conflicting. We sought to determine the independent association of ethnicity and all-cause mortality over two decades of follow-up of Israeli patients. Methods: Our study comprised 15,524 patients including 958 (6%) Arab patients who had been previously enrolled in the Bezafibrate Infarction Prevention (BIP) registry between February 1, 1990, and October 31, 1992, and subsequently followed-up for long-term mortality. We compared clinical characteristics and outcomes of Israeli Arabs and Jews. Propensity score matching (PSM) (1:2 ratios) was used for validation. Results: Arab patients were significantly younger (56 ± 7 years vs. 60 ± 7 years; p < 0.001; respectively), and had more cardiovascular disease (CVD) risk factors. Kaplan-Meier survival analysis showed that all-cause mortality was significantly higher among Arab patients (67 vs. 61%; log-rank p < 0.001). Multivariate adjusted analysis showed that mortality risk was 49% greater (HR 1.49; 95% CI: 1.37–1.62; p < 0.001) among Arabs. Conclusions: Arab ethnicity is independently associated with an increased 20-year all-cause mortality among patients with established IHD.
KW - all-cause mortality
KW - disparity
KW - ethnicity
KW - heart disease
KW - ischemic heart disease
UR - http://www.scopus.com/inward/record.url?scp=85143614381&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2021.661390
DO - 10.3389/fcvm.2021.661390
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:85143614381
SN - 2297-055X
VL - 8
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 661390
ER -